Does AMIVANTAMAB Cause Respiratory failure? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Respiratory failure have been filed in association with AMIVANTAMAB (Rybrevant). This represents 1.1% of all adverse event reports for AMIVANTAMAB.
8
Reports of Respiratory failure with AMIVANTAMAB
1.1%
of all AMIVANTAMAB reports
6
Deaths
7
Hospitalizations
How Dangerous Is Respiratory failure From AMIVANTAMAB?
Of the 8 reports, 6 (75.0%) resulted in death, 7 (87.5%) required hospitalization, and 6 (75.0%) were considered life-threatening.
Is Respiratory failure Listed in the Official Label?
Yes, Respiratory failure is listed as a known adverse reaction in the official FDA drug label for AMIVANTAMAB.
What Other Side Effects Does AMIVANTAMAB Cause?
Infusion related reaction (62)
Rash (61)
Pulmonary embolism (41)
Dermatitis acneiform (34)
Thrombocytopenia (33)
Paronychia (29)
Diarrhoea (25)
Pneumonitis (24)
Dyspnoea (23)
Nausea (23)
What Other Drugs Cause Respiratory failure?
PREDNISONE (2,299)
CYCLOPHOSPHAMIDE (2,096)
RITUXIMAB (1,838)
TACROLIMUS (1,758)
METHOTREXATE (1,685)
DEXAMETHASONE (1,603)
MYCOPHENOLATE MOFETIL (1,469)
METHYLPREDNISOLONE (1,442)
PREDNISOLONE (1,346)
VINCRISTINE (1,120)
Which AMIVANTAMAB Alternatives Have Lower Respiratory failure Risk?
AMIVANTAMAB vs AMIVANTAMAB-VMJW
AMIVANTAMAB vs AMLODIPINE
AMIVANTAMAB vs AMLODIPINE BESILATE
AMIVANTAMAB vs AMLODIPINE\ATORVASTATIN
AMIVANTAMAB vs AMLODIPINE\BENAZEPRIL